Role of human cripto-1 in tumor angiogenesis. (Q40469506)

20 September 2017

title

Role of human cripto-1 in tumor angiogenesis. (English)

1 reference

20 September 2017

1 reference

6

1 reference

William G Stetler-Stevenson

20 September 2017

17

1 reference

20 September 2017

Caterina Bianco

1

1 reference

20 September 2017

Luigi Strizzi

2

1 reference

20 September 2017

Andreas Ebert

3

1 reference

20 September 2017

Cindy Chang

4

1 reference

20 September 2017

Aasia Rehman

5

1 reference

20 September 2017

Liliana Guedez

7

1 reference

20 September 2017

Rita Salloum

8

1 reference

20 September 2017

Erika Ginsburg

9

1 reference

20 September 2017

Youping Sun

10

1 reference

20 September 2017

Nadia Khan

11

1 reference

20 September 2017

Morihisa Hirota

12

1 reference

20 September 2017

Brenda Wallace-Jones

13

1 reference

20 September 2017

Christian Wechselberger

14

1 reference

20 September 2017

Barbara K Vonderhaar

15

1 reference

20 September 2017

Giovanna Tosato

16

1 reference

20 September 2017

Michele Sanicola

18

1 reference

20 September 2017

David S Salomon

19

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Journal of the National Cancer Institute

20 September 2017

published in

1 reference

20 September 2017

volume

97

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

132-141

1 reference

The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

The EGF-CFC gene family in vertebrate development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Nodal Signaling in Vertebrate Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Fucosylation of Cripto is required for its ability to facilitate nodal signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Quantitative Assessment of Angiogenic Responses by the Directed in Vivo Angiogenesis Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

Cripto forms a complex with activin and type II activin receptors and can block activin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI011

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI011

1 reference

20 September 2017

1 reference